Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PSMD7 pseudogene 3 (PSMD7P3) is a non-functional genomic sequence related to the PSMD7 gene, which encodes a non-ATPase subunit of the 19S regulator of the 26S proteasome[1][5]. Pseudogenes such as PSMD7P3 do not produce a functional protein and are not considered relevant as therapeutic targets, receptors, or enzymes. While the functional PSMD7 gene is implicated in proteasome activity, cell cycle regulation, and cancer biology[2][3], PSMD7P3 itself is not a therapeutic target and has no established biological or clinical significance[1][5]. Note: If you were seeking information about the functional proteasome subunit, the canonical entry should be "Proteasome 26S subunit, non-ATPase 7 (PSMD7)". PSMD7 itself is an active enzyme complex subunit and has roles in protein degradation and disease, but PSMD7P3 is just a pseudogene and not biologically or clinically relevant as a drug target[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PSMD7 pseudogene 3 (PSMD7P3).